{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:41Z","timestamp":1791923081477,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ygyno.2022.06.027","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T21:00:25Z","timestamp":1657659625000},"page":"530-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials"],"prefix":"10.1016","volume":"166","author":[{"given":"A.S.V.M.","family":"van den Heerik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.T.S.","family":"Aiyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Stelloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.","family":"J\u00fcrgenliemk-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.H.W.","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Jobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.M.","family":"Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"van der Steen-Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.T.H.B.M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Horeweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2022.06.027_bb0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance","volume":"22","author":"Murray","year":"2003","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.06.027_bb0010","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/modpathol.2009.33","article-title":"Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands","volume":"22","author":"Stewart","year":"2009","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2559.2009.03327.x","article-title":"Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition","volume":"55","author":"Stewart","year":"2009","journal-title":"Histopathology."},{"issue":"5","key":"10.1016\/j.ygyno.2022.06.027_bb0020","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/PGP.0b013e3182158944","article-title":"Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium","volume":"30","author":"Stewart","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/his.12057","article-title":"Epithelial-mesenchymal transition in carcinomas of the female genital tract","volume":"62","author":"Stewart","year":"2013","journal-title":"Histopathology."},{"issue":"7","key":"10.1016\/j.ygyno.2022.06.027_bb0030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2009.069500","article-title":"KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion","volume":"63","author":"Stewart","year":"2010","journal-title":"J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.ygyno.2022.06.027_bb0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/PAS.0000000000000856","article-title":"Clinicopathologic association and prognostic value of microcystic, elongated, and fragmented (MELF) pattern in endometrial Endometrioid carcinoma","volume":"41","author":"Kihara","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.06.027_bb0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell."},{"issue":"10","key":"10.1016\/j.ygyno.2022.06.027_bb0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12094-012-0866-3","article-title":"The EMT signaling pathways in endometrial carcinoma","volume":"14","author":"Colas","year":"2012","journal-title":"Clin. Transl. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.06.027_bb0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/00313020903041135","article-title":"MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion","volume":"41","author":"Stewart","year":"2009","journal-title":"Pathology."},{"issue":"2","key":"10.1016\/j.ygyno.2022.06.027_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PGP.0b013e318285657b","article-title":"Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis","volume":"33","author":"Hertel","year":"2014","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PAS.0000000000000754","article-title":"The microcystic, elongated, and fragmented (MELF) pattern of invasion: a single institution report of 464 consecutive FIGO grade 1 endometrial endometrioid adenocarcinomas","volume":"41","author":"Joehlin-Price","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.06.027_bb0065","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/PAS.0b013e318299f2ab","article-title":"The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma","volume":"37","author":"Euscher","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.06.027_bb0070","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2559.2011.03802.x","article-title":"MELF invasion in endometrial cancer as a risk factor for lymph node metastasis","volume":"58","author":"Pavlakis","year":"2011","journal-title":"Histopathology."},{"key":"10.1016\/j.ygyno.2022.06.027_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.humpath.2017.05.026","article-title":"Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance","volume":"70","author":"Espinosa","year":"2017","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.06.027_bb0080","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4132\/jptm.2017.07.19","article-title":"The potential roles of MELF-pattern, microvessel density, and VEGF expression in survival of patients with Endometrioid endometrial carcinoma: a Morphometrical and Immunohistochemical analysis of 100 cases","volume":"51","author":"Zinovkin","year":"2017","journal-title":"J. Pathol. Transl. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/PGP.0000000000000370","article-title":"MELF pattern for predicting lymph node involvement and survival in grade I-II endometrioid-type endometrial cancer","volume":"37","author":"Sanci","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.06.027_bb0090","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00432-017-2474-7","article-title":"Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma","volume":"143","author":"Kommoss","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2020.07.102","article-title":"POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women","volume":"159","author":"He","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"7447","key":"10.1016\/j.ygyno.2022.06.027_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature."},{"issue":"16","key":"10.1016\/j.ygyno.2022.06.027_bb0105","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and Clinicopathological factors in early-stage endometrial Cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"29","key":"10.1016\/j.ygyno.2022.06.027_bb0110","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial Cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"9213","key":"10.1016\/j.ygyno.2022.06.027_bb0115","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"9717","key":"10.1016\/j.ygyno.2022.06.027_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"15","key":"10.1016\/j.ygyno.2022.06.027_bb0125","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.ejca.2014.07.014","article-title":"L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results","volume":"50","author":"Bosse","year":"2014","journal-title":"Europ. J. Cancer (Oxf. Engl. 1990)"},{"issue":"1;41(3)","key":"10.1016\/j.ygyno.2022.06.027_bb0130","first-page":"220","article-title":"Defining substantial Lymphovascular space invasion in endometrial Cancer","volume":"May","author":"Peters","year":"2021","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.027_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of molecular characteristics into endometrial cancer management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology."},{"key":"10.1016\/j.ygyno.2022.06.027_bb0145","series-title":"WHO Classification of Female Genital Tumours","author":"Board WCoTE","year":"2020"},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.027_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAP.0b013e31828d17cc","article-title":"Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications","volume":"20","author":"Cole","year":"2013","journal-title":"Adv. Anat. Pathol."},{"issue":"13","key":"10.1016\/j.ygyno.2022.06.027_bb0155","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Europ. J. Cancer (Oxf. Engl. 1990)"},{"issue":"11","key":"10.1016\/j.ygyno.2022.06.027_bb0160","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study","volume":"58","author":"St\u00e5lberg","year":"2019","journal-title":"Acta Oncol. (Stockholm, Sweden)"},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2022.06.027_bb0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/his.12254","article-title":"Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma","volume":"64","author":"Han","year":"2014","journal-title":"Histopathology."},{"issue":"6","key":"10.1016\/j.ygyno.2022.06.027_bb0175","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00428-021-03176-5","article-title":"Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma","volume":"479","author":"Ruz-Caracuel","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2022.06.027_bb0180","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fonc.2019.01255","article-title":"RAS, cellular plasticity, and tumor budding in colorectal Cancer","volume":"9","author":"Maffeis","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.06.027_bb0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.ygyno.2022.06.027_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209294","article-title":"L1 cell adhesion molecule (L1CAM) expression in endometrioid endometrial carcinomas: a possible pre-operative surrogate of lymph vascular space invasion","volume":"13","author":"de Freitas","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ygyno.2022.06.027_bb0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PGP.0000000000000384","article-title":"Microcystic, elongated, and fragmented pattern invasion in ovarian Endometrioid carcinoma: Immunohistochemical profile and prognostic implications","volume":"37","author":"Goldberg","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.06.027_bb0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/PGP.0000000000000633","article-title":"Clinicopathologic association and prognostic value of MELF pattern in invasive Endocervical adenocarcinoma (ECA) as classified by IECC","volume":"39","author":"Segura","year":"2020","journal-title":"Int. J. Gynecol. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822004310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822004310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:01:40Z","timestamp":1758772900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822004310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0090825822004310"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.06.027","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}